Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

Troponin in Critical Illness

EF 2015-16

Résumé
Troponin levels as measured in the blood are markers of heart injury. Elevated troponin levels are needed as proof of a heart attack. In the intensive care unit (ICU), critically ill patients are frequently found to have increased troponin levels. In these patients, it is difficult to identify the difference between an increase in troponin from a true heart attack. Many critically ill patients with an increased troponin level do meet the criteria for a heart attack, while some do not. Troponin elevations also seem to be associated with an increased risk of death in the ICU, whether patients are actually diagnosed with heart attack or not. Doctors do not know how to treat these patients with elevated troponin levels or whether they require treatment. Using different study types, we will 1) Describe how frequent troponin elevations are in critical illness and the associated risk of death. 2) Describe how doctors currently treat critically ill patients presenting with troponin elevations. 3) Explore if drugs used in the treatment of myocardial infarction may be beneficial in critically ill patients in general and specifically in those with troponin elevations. 4) Evaluate whether doctors involved in the care of patients with troponin elevations consider that they are associated with mortality and need to be treated. The studies that will be conducted during this PhD are part of the TROPICS (Troponins in Critical Illness) Research Program. This program will advance knowledge on the impact on mortality as a result of troponin elevations in critical illness and explore potential treatments in ICU patients with troponin elevations. The information acquired through this work will lead to a therapy trial in this patient population. Our greater objective is to improve the care of critically ill patients with troponin elevations.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
347976
Name
Belley-Côté Emilie Prudence
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Troponin in Critical Illness
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Critical Illness; Troponins
Abstract
Troponin levels as measured in the blood are markers of heart injury. Elevated troponin levels are needed as proof of a heart attack. In the intensive care unit (ICU), critically ill patients are frequently found to have increased troponin levels. In these patients, it is difficult to identify the difference between an increase in troponin from a true heart attack. Many critically ill patients with an increased troponin level do meet the criteria for a heart attack, while some do not. Troponin elevations also seem to be associated with an increased risk of death in the ICU, whether patients are actually diagnosed with heart attack or not. Doctors do not know how to treat these patients with elevated troponin levels or whether they require treatment. Using different study types, we will 1) Describe how frequent troponin elevations are in critical illness and the associated risk of death. 2) Describe how doctors currently treat critically ill patients presenting with troponin elevations. 3) Explore if drugs used in the treatment of myocardial infarction may be beneficial in critically ill patients in general and specifically in those with troponin elevations. 4) Evaluate whether doctors involved in the care of patients with troponin elevations consider that they are associated with mortality and need to be treated. The studies that will be conducted during this PhD are part of the TROPICS (Troponins in Critical Illness) Research Program. This program will advance knowledge on the impact on mortality as a result of troponin elevations in critical illness and explore potential treatments in ICU patients with troponin elevations. The information acquired through this work will lead to a therapy trial in this patient population. Our greater objective is to improve the care of critically ill patients with troponin elevations.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Belley-Côté, Emilie Prudence
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~